Position:Senior Research Statistician
Ruth is a Senior Research Statistician at the Diabetes Trials Unit.
Her ongoing projects include the expansion of the UKPDS Risk Engine to include estimates of both cardiovascular and microvascular disease risk, and modelling life expectancy in type 2 diabetes.
She is currently the statistical lead for the ACE study.
Design and rationale of the EMPA-VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Moritz J. Hundertmark et al.
ESC Heart Failure 2021
Predicting the Risk of Developing Type 2 diabetes in Chinese People who have Coronary Heart Disease and Impaired Glucose Tolerance
Shishi Xu et al.
J Diabetes 2021
Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension: A Systematic Review and Individual Participant-based Meta-analysis
Stephen P Juraschek et al.
Ann Int Med. 2020;174:58-68
Predicting Heart Failure Events in Patients with Coronary Heart Disease and Impaired Glucose Tolerance: Insights from the Acarbose Cardiovascular Evaluation (ACE) trial
Malgorzata Wamil et al.
Diabetes Res Clin Pract. 2020;170:108488
Long-term glucose variability and risk of nephropathy complication in UKPDS, ACCORD and VADT trials
Jin J. Zhou et al.
Risk of anemia with metformin use in type 2 diabetes: A MASTERMIND study
Louise A Donnelly et al.
Diabetes Care 2020;43:2493-2499